吉瑞治疗 GYRE
$4.76 +$0.75 (+18.70%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $4.76 0.00%
开盘$4.56
昨收$4.01
当日区间$4.08 – $4.79
成交量359.7K
市值$504.72M
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$29.11M-2.1% YoY
营业利润-$13.86M-518.8% YoY
净利润-$14.27M-537.9% YoY
摊薄每股收益-$0.12-300.0% YoY
自由现金流-$18.01M-130.0% YoY
经营现金流-$16.73M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率93.8%
营业利润率-13.9%
净利率-18.1%
净资产收益率-19.9%
资产收益率-11.3%
投入资本回报率-20.3%
流动比率4.26
负债/资产比率28.5%
现金及投资$74.80M
总负债$2.03M
净现金（净负债）$72.76M
营收构成
2026/Q2 季度
按业务线
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $29.11M | $22.52M | $116.59M | $37.20M | $30.56M |
| 营业总收入 | $29.11M | $22.52M | $116.59M | $37.20M | $30.56M |
| 营业成本 | $2.21M | $1.23M | $5.42M | $1.74M | $1.63M |
| 毛利润 | $26.90M | $21.29M | $111.17M | $35.45M | $28.94M |
| 营业费用 | $40.76M | $28.09M | $99.68M | $35.33M | $22.01M |
| 销售及管理费用 | $21.62M | $21.36M | $85.98M | $30.52M | $19.65M |
| -销售及营销费用 | $13.75M | $14.14M | $65.18M | $23.82M | $15.33M |
| -管理费用 | $7.87M | $7.22M | $20.80M | $6.70M | $4.32M |
| 研发费用 | $19.14M | $6.74M | $13.70M | $4.82M | $2.36M |
| 营业利润 | -$13.86M | -$6.80M | $11.49M | $120,000.00 | $6.93M |
| 非经营性利息净收入（支出） | $740,000.00 | – | $1.75M | – | – |
| 非经营性利息收入 | $740,000.00 | – | $1.75M | – | – |
| 其他收入（支出） | -$1.31M | -$2.44M | $1.20M | -$1.93M | $703,000.00 |
| 证券出售收益 | $132,000.00 | $89,000.00 | $2.71M | $263,000.00 | -$23,000.00 |
| 特殊收益（费用） | -$502,000.00 | -$2.55M | -$4,000.00 | -$2,000.00 | -$1,000.00 |
| -减：重组及并购费用 | $502,000.00 | $2.55M | – | – | – |
| 其他非经营性收入（支出） | -$943,000.00 | $29,000.00 | -$1.51M | -$2.19M | $727,000.00 |
| 税前利润 | -$14.43M | -$9.24M | $14.44M | -$66,000.00 | $7.63M |
| 税费 | -$164,000.00 | $621,000.00 | $4.56M | $1.30M | $1.69M |
| 净利润 | -$14.27M | -$9.86M | $9.88M | -$1.37M | $5.94M |
| 持续经营利润 | -$14.27M | -$9.86M | $9.88M | -$1.37M | $5.94M |
| 少数股东权益 | -$3.67M | -$1.17M | $4.85M | $357,000.00 | $2.33M |
| 归属母公司净利润 | -$10.61M | -$8.69M | $5.03M | -$1.72M | $3.61M |
| 优先股股息 | $1.06M | – | – | – | – |
| 归属普通股股东净利润 | -$11.66M | -$8.69M | $5.03M | -$1.72M | $3.61M |
| 基本每股收益 | -$0.12 | -$0.10 | $0.06 | -$0.02 | $0.04 |
| 摊薄每股收益 | -$0.12 | -$0.10 | $0.02 | -$0.02 | $0.03 |
| -固定资产出售收益 | – | – | -$4,000.00 | -$2,000.00 | -$1,000.00 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $199.26M | $162.02M | $166.13M | $166.13M | $159.38M |
| 流动资产合计 | $122.07M | $91.73M | $102.37M | $102.37M | $98.58M |
| 现金及现金等价物与短期投资 | $74.80M | $49.81M | $52.43M | $52.43M | $60.05M |
| -现金及现金等价物 | $43.29M | $37.50M | $37.07M | $37.07M | $40.40M |
| -短期投资 | $31.51M | $12.31M | $15.36M | $15.36M | $19.65M |
| 应收款 | $28.25M | $26.81M | $36.95M | $36.95M | $26.80M |
| -应收账款 | $27.76M | $22.76M | $31.08M | $31.08M | $25.88M |
| -应收票据 | $232,000.00 | $3.82M | $5.64M | $5.64M | $693,000.00 |
| -其他应收款 | $255,000.00 | $230,000.00 | $230,000.00 | $230,000.00 | $230,000.00 |
| 存货 | $11.43M | $11.35M | $10.17M | $10.17M | $8.85M |
| 其他流动资产 | $7.60M | $3.76M | $1.49M | $1.49M | – |
| 非流动资产合计 | $77.18M | $70.28M | $63.76M | $63.76M | $60.81M |
| 固定资产净值 | $27.28M | $23.57M | $24.73M | $24.73M | $23.61M |
| -固定资产原值 | $39.98M | $31.74M | $32.31M | $32.31M | $30.54M |
| -累计折旧 | -$12.70M | -$8.17M | -$7.58M | -$7.58M | -$6.93M |
| 投资及预付款 | $28.44M | $29.42M | $23.52M | $23.52M | $20.32M |
| -可供出售证券 | $28.44M | $29.42M | $23.52M | $23.52M | $20.32M |
| 一年以上预付资产 | $302,000.00 | – | – | – | – |
| 商誉及其他无形资产 | $4.53M | $4.63M | $6.15M | $6.15M | $4.85M |
| -其他无形资产 | $4.53M | $4.63M | $6.15M | $6.15M | $4.85M |
| 一年以上递延资产 | $9.28M | $7.72M | $6.87M | $6.87M | $6.71M |
| 其他非流动资产 | $7.34M | $4.94M | $2.49M | $2.49M | $5.32M |
| 负债合计 | $56.77M | $25.03M | $23.85M | $23.85M | $21.97M |
| 流动负债合计 | $28.66M | $19.79M | $18.29M | $18.29M | $15.91M |
| 应付款 | $11.50M | $7.16M | $5.72M | $5.72M | $7.13M |
| -应付账款 | $1.24M | $265,000.00 | $124,000.00 | $124,000.00 | $556,000.00 |
| -应付税款合计 | $2.35M | $3.13M | $2.94M | $2.94M | $2.65M |
| -一年内应付关联方款项 | $5.09M | $226,000.00 | $227,000.00 | $227,000.00 | $228,000.00 |
| -其他应付款 | $2.83M | $3.54M | $2.43M | $2.43M | $3.70M |
| 一年内应计费用 | $15.49M | $11.76M | $11.81M | $11.81M | $7.96M |
| 短期债务及融资租赁负债 | $1.39M | $751,000.00 | $636,000.00 | $636,000.00 | $626,000.00 |
| -一年内到期融资租赁负债 | $1.39M | $751,000.00 | $636,000.00 | $636,000.00 | $626,000.00 |
| 一年内递延负债 | $189,000.00 | $99,000.00 | $111,000.00 | $111,000.00 | $154,000.00 |
| 非流动负债合计 | $28.10M | $5.24M | $5.56M | $5.56M | $6.06M |
| 长期债务及融资租赁负债 | $2.03M | $72,000.00 | $303,000.00 | $303,000.00 | $539,000.00 |
| -长期融资租赁负债 | $2.03M | $72,000.00 | $303,000.00 | $303,000.00 | $539,000.00 |
| 衍生产品负债 | $2.74M | $2.87M | $2.96M | $2.96M | $3.22M |
| 一年以上递延负债 | $829,000.00 | $840,000.00 | $852,000.00 | $852,000.00 | $866,000.00 |
| 可转换优先证券 | $22.43M | – | – | – | – |
| 其他非流动负债 | $70,000.00 | $1.46M | $1.45M | $1.45M | $1.43M |
| 股东权益合计 | $142.49M | $136.99M | $142.28M | $142.28M | $137.42M |
| 股东权益 | $107.93M | $101.31M | $106.03M | $106.03M | $101.92M |
| 股本 | $106,000.00 | $91,000.00 | $91,000.00 | $91,000.00 | $91,000.00 |
| -普通股 | $106,000.00 | $91,000.00 | $91,000.00 | $91,000.00 | $91,000.00 |
| 资本公积 | $240.64M | $174.65M | $172.05M | $172.05M | $167.13M |
| 留存收益 | -$137.96M | -$77.67M | -$68.43M | -$68.43M | -$66.70M |
| 不影响留存收益的损益 | $5.14M | $4.23M | $2.32M | $2.32M | $1.40M |
| 少数股东权益 | $34.56M | $35.68M | $36.25M | $36.25M | $35.50M |
| 预付资产 | – | – | $1.34M | $1.34M | $2.87M |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$16.73M | $3.18M | $1.01M | -$5.63M | $14.24M |
| 持续经营经营活动现金流净额 | -$16.73M | $3.18M | $1.01M | -$5.63M | $14.24M |
| 持续经营净利润 | -$22.99M | -$9.86M | $9.88M | -$1.37M | $8.54M |
| 持续经营损益 | -$68,000.00 | -$52,000.00 | -$2.59M | -$241,000.00 | $42,000.00 |
| 折旧、折耗与摊销 | $1.48M | $672,000.00 | $2.52M | $695,000.00 | $281,000.00 |
| 递延税款 | -$1.43M | -$738,000.00 | -$1.11M | -$87,000.00 | -$531,000.00 |
| 其他非现金项目 | -$328,000.00 | $864,000.00 | $791,000.00 | $277,000.00 | -$474,000.00 |
| 营运资金变动 | $4.56M | $9.51M | -$15.58M | -$9.47M | $5.81M |
| -应收款变动 | -$1.00M | $10.48M | -$11.95M | -$9.67M | -$1.19M |
| -存货变动 | $94,000.00 | -$1.02M | -$3.63M | -$1.21M | $72,000.00 |
| -预付资产变动 | $2.98M | -$912,000.00 | -$206,000.00 | -$509,000.00 | $1.01M |
| -应付账款及应计费用变动 | $3.03M | $966,000.00 | $1.00M | $2.21M | -$2.33M |
| -其他流动负债变动 | -$536,000.00 | $0.00 | -$791,000.00 | -$283,000.00 | $51,000.00 |
| 投资活动现金流净额 | $9.76M | -$3.06M | -$474,000.00 | $1.85M | -$5.64M |
| 持续经营投资活动现金流净额 | $9.76M | -$3.06M | -$474,000.00 | $1.85M | -$5.64M |
| 固定资产购置及出售净额 | -$255,000.00 | -$172,000.00 | -$1.16M | -$133,000.00 | -$589,000.00 |
| 无形资产购置及出售净额 | -$1.02M | -$5,000.00 | -$733,000.00 | $4,000.00 | -$15,000.00 |
| 投资购置及出售净额 | $11.04M | -$2.88M | $1.42M | $1.98M | -$5.04M |
| 筹资活动现金流 | -$8,000.00 | $21,000.00 | $24.38M | $318,000.00 | $2.47M |
| 持续经营筹资活动现金流净额 | -$8,000.00 | $21,000.00 | $24.38M | $318,000.00 | $2.47M |
| 普通股发行净额 | $0.00 | $0.00 | $23.51M | $0.00 | $0.00 |
| 股票期权行使所得 | $200,000.00 | $21,000.00 | $2.36M | $318,000.00 | $50,000.00 |
| 期末现金余额 | $43.29M | $37.50M | $37.07M | $37.07M | $40.40M |
| 现金净变动 | -$6.98M | $146,000.00 | $24.91M | -$3.46M | $11.07M |
| 期初现金余额 | $37.50M | $37.07M | $11.81M | $40.40M | $56.37M |
| 汇率变动影响 | $643,000.00 | $285,000.00 | $343,000.00 | $127,000.00 | $206,000.00 |
| 自由现金流 | -$18.01M | $3.00M | -$913,000.00 | -$5.77M | $13.63M |
| 业务购买及出售净额 | – | – | $0.00 | $0.00 | – |
| 其他筹资费用净额 | – | – | -$1.49M | $0.00 | $2.42M |
暂无评论——快来第一个聊聊 GYRE。
登录后参与讨论。